+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Area Market Research Reports

From
From
From
United States External Cardiology Remote Monitors Market Outlook to 2033 - Product Thumbnail Image

United States External Cardiology Remote Monitors Market Outlook to 2033

  • Report
  • December 2024
  • 20 Pages
  • United States
From
2024 Endocrine Testing Market for 20 Assays: US, Europe, Japan - Supplier Shares and Strategies, Profiles of Leading Competitors - Product Thumbnail Image

2024 Endocrine Testing Market for 20 Assays: US, Europe, Japan - Supplier Shares and Strategies, Profiles of Leading Competitors

  • Report
  • September 2024
  • 327 Pages
  • Europe, United States, ... Europe, United States, Japan
From
From
From
From
From
From
From
From
From
Pain Management Physicians in the US - Industry Market Research Report - Product Thumbnail Image

Pain Management Physicians in the US - Industry Market Research Report

  • Report
  • December 2024
  • 52 Pages
  • United States
From
Loading Indicator

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs. Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more